Last reviewed · How we verify
BR1733
At a glance
| Generic name | BR1733 |
|---|---|
| Sponsor | Shanghai Blueray Biopharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |